Schedule 13G ownership disclosure

DiaMedica Therapeutics Inc

Security class unavailable · CUSIP: 25253X207

Event date: 2020-12-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
929,705
Percent of class
4.9610%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001437749-20-025881
Form type
SC 13G/A
Filer
DiaMedica Therapeutics Inc.
CIK
CIK 1401040
Filed
Dec 23, 2020
Reporting period
Dec 15, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub